Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO4995819 as Adjunct Therapy in Major Depressive Disorder
NCT01733654Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- Sep 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Decoglurant in major depressive disorder (MDD), sponsored by Stanford University. Planned start Sep 2012; status: withdrawn.
02
Drugs
Decoglurant
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01733654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01733654.